Insulet
PODD
#1041
Rank
S$24.92 B
Marketcap
$355.37
Share price
-0.81%
Change (1 day)
27.15%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$2.57 Billion

According to Insulet's latest financial reports the company's total liabilities are S$2.57 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insulet - Total liabilities on balance sheet (from 2005 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$2.45 B3%
2022-12-31S$2.37 B17.91%
2021-12-31S$2.01 B20.16%
2020-12-31S$1.67 B16.73%
2019-12-31S$1.43 B46.94%
2018-12-31S$0.97 B11.2%
2017-12-31S$0.88 B54.59%
2016-12-31S$0.56 B67.01%
2015-12-31S$0.34 B20.96%
2014-12-31S$0.28 B36.21%
2013-12-31S$0.20 B9.98%
2012-12-31S$0.18 B4.85%
2011-12-31S$0.17 B54.81%
2010-12-31S$0.11 B-30.48%
2009-12-31S$0.16 B45.54%
2008-12-31S$0.11 B107.02%
2007-12-31S$55.35 M-77.28%
2006-12-31S$0.24 B76.57%
2005-12-31S$0.13 B18.09%
2004-12-31S$0.11 B93.16%
2003-12-31S$60.49 M-3.59%
2002-12-31S$62.74 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$3.04 B 18.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.97 B-62.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.90 B 129.36%๐Ÿ‡บ๐Ÿ‡ธ USA
S$145.91 B 5,568.92%๐Ÿ‡บ๐Ÿ‡ธ USA
S$46.32 B 1,699.73%๐Ÿ‡บ๐Ÿ‡ธ USA
S$55.76 B 2,066.61%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$82.70 B 3,113.08%๐Ÿ‡บ๐Ÿ‡ธ USA